These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9516600)

  • 41. Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer.
    Chan A; Conte PF; Petruzelka L; Tubiana-Mathieu N; Ganju V; Llombart A; Espie M; Majois F; Gil MG; Vaissiere N; Villanova G
    Anticancer Res; 2013 Jun; 33(6):2657-64. PubMed ID: 23749924
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of anthracyclines and paclitaxel as first line chemotherapy in patients with visceral metastases of breast cancer.
    Rossi D; Graziano F; Luzi Fedeli S; Fedeli A; Alessandroni P; Catalano V; Giordani P; Testa E; Catalano G
    Minerva Med; 2002 Aug; 93(4):303-7. PubMed ID: 12207200
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Colitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancer.
    Ibrahim NK; Sahin AA; Dubrow RA; Lynch PM; Boehnke-Michaud L; Valero V; Buzdar AU; Hortobagyi GN
    Lancet; 2000 Jan; 355(9200):281-3. PubMed ID: 10675076
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-utility analysis of chemotherapy using paclitaxel, docetaxel, or vinorelbine for patients with anthracycline-resistant breast cancer.
    Leung PP; Tannock IF; Oza AM; Puodziunas A; Dranitsaris G
    J Clin Oncol; 1999 Oct; 17(10):3082-90. PubMed ID: 10506603
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Simultaneous infusion of vinorelbin and taxol as first-line chemotherapy in metastasized breast cancer].
    Vici P; Conti F; Amodio A; Belli F; Della Giulia M; Mariotti S; Gionfra T; Lopez M
    Clin Ter; 1998; 149(4):255-9. PubMed ID: 9866885
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A phase II study of paclitaxel in advanced breast cancer resistant to anthracyclines.
    Fountzilas G; Athanassiades A; Giannakakis T; Bafaloukos D; Karakousis K; Dombros N; Kosmidis P; Skarlos D
    Eur J Cancer; 1996 Jan; 32A(1):47-51. PubMed ID: 8695240
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Paclitaxel plus epirubicin in advanced breast cancer.
    Conte PF; Gennari A; Salvadori B; Pazzagli C; Bengala C
    Oncology (Williston Park); 1998 Jan; 12(1 Suppl 1):40-4. PubMed ID: 9516603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current status of vinorelbine for breast cancer.
    Smith GA
    Oncology (Williston Park); 1995 Aug; 9(8):767-73; discussion 774, 776, 779. PubMed ID: 7577376
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Paclitaxel plus doxorubicin in metastatic breast Ca: the Milan experience.
    Gianni L
    Oncology (Williston Park); 1998 Jan; 12(1 Suppl 1):13-5. PubMed ID: 9516596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase II trial of weekly i.v. vinorelbine as a single agent in first-line advanced breast cancer chemotherapy. The Latin-American experience.
    Bruno S; Puerto VL; Mickiewicz E; Hegg R; Texeira LC; Gaitan L; Martinez L; Fernandez O; Otero J; Kesselring G
    Am J Clin Oncol; 1995 Oct; 18(5):392-6. PubMed ID: 7572754
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapy.
    Rivera E; Holmes FA; Frye D; Valero V; Theriault RL; Booser D; Walters R; Buzdar AU; Dhingra K; Fraschini G; Hortobagyi GN
    Cancer; 2000 Dec; 89(11):2195-201. PubMed ID: 11147589
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment with a nonanthracycline regimen in advanced breast cancer: vinorelbine, cyclophosphamide, and 5-fluorouracil with folinic acid.
    Turpin F; Lluch A; Closon MH; Gruia G; Llombart A; Fernandez R; Delgado FM; Biville F
    Am J Clin Oncol; 1999 Apr; 22(2):196-8. PubMed ID: 10199461
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multicenter phase II trial of weekly paclitaxel in women with metastatic breast cancer.
    Perez EA; Vogel CL; Irwin DH; Kirshner JJ; Patel R
    J Clin Oncol; 2001 Nov; 19(22):4216-23. PubMed ID: 11709565
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase I study of vinorelbine by 96-hour infusion in advanced metastatic breast cancer.
    Ibrahim NK; Valero V; Theriault RL; Willey J; Walters RS; Buzdar AU; Booser DJ; Hortobagyi GN
    Am J Clin Oncol; 2000 Apr; 23(2):117-21. PubMed ID: 10776969
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Absence of major peripheral neuropathy in a phase II trial of ifosfamide with vinorelbine in patients with ovarian cancer previously treated with platinum and paclitaxel.
    Fleming GF; Waggoner SE; Rotmensch J; Langhauser C
    Am J Clin Oncol; 2001 Feb; 24(1):52-7. PubMed ID: 11232950
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vinorelbine (navelbine) as a salvage treatment for advanced breast cancer.
    Degardin M; Bonneterre J; Hecquet B; Pion JM; Adenis A; Horner D; Demaille A
    Ann Oncol; 1994 May; 5(5):423-6. PubMed ID: 8075049
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment outcomes with vinorelbine for metastatic breast cancer patients previously treated with both doxorubicin and docetaxel].
    Tashiro H; Sonoda K; Ohshiro T; Ohta M; Yamamura S; Ishikawa T; Itasaka H; Matsusaka T; Kume K
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1397-401. PubMed ID: 11681247
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vinorelbine: an active, non cross-resistant drug in advanced breast cancer. Results from a phase II study.
    Terenziani M; Demicheli R; Brambilla C; Ferrari L; Moliterni A; Zambetti M; Caraceni A; Martini C; Bonadonna G
    Breast Cancer Res Treat; 1996; 39(3):285-91. PubMed ID: 8877008
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vinorelbine-induced neurotoxicity in patients with advanced breast cancer pretreated with paclitaxel--a phase II study.
    Fazeny B; Zifko U; Meryn S; Huber H; Grisold W; Dittrich C
    Cancer Chemother Pharmacol; 1996; 39(1-2):150-6. PubMed ID: 8995513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Australian multicentre phase II trial of paclitaxel in women with metastatic breast cancer and prior chemotherapy.
    Michael M; Bishop JF; Levi JA; Bell DR; Zalcberg JR; Friedlander ML; Olver IN; Smith JG; Toner GC
    Med J Aust; 1997 May; 166(10):520-3. PubMed ID: 9196484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.